Cell therapy, AI drug discovery highlight 2021’s record year in biotech IPOs

[cafead]

via The biggest biotech IPO of 2021 belongs to a cell therapy developer that has yet to reach the clinic. Cell therapy and artificial intelligence were hot categories of newly public companies, but even though IPOs reached record levels this year that streak is not expected to continue in 2022.

article source